ArticleThe journal of pain2025
High-impact pain predicts subjective cognitive decline and interacts with APOE4 genotype in the development of objective cognitive impairment.
Article in The journal of pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Latent profile analysis of self-neglect and associated factors among rural older adults with chronic diseases: a cross-sectional study.Frontiers in public health · 2026Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
Chronic pain is the most common health challenge for older adults and a significant risk factor for cognitive impairments and dementia. This study examined the relationship of high-impact pain (i.e., pain that limits daily activities) with subjective cognitive decline (SCD) and objective cognitive impairment in 13,763 adults aged 50 and older from the Health and Retirement Study (2004-2020). High-impact pain was associated with a higher prevalence (32.4%) and incidence of SCD compared to no pain (18.0%) and low-impact pain (21.3%). High-impact pain also predicted an increased risk of objective cognitive impairment, particularly in individuals without the APOE4 allele. The adjusted hazard ratio (aHR) for incident SCD in high-impact pain versus no pain was 1.31 (95% CI: 1.31, 1.42). The aHR for objective cognitive impairment compared to no or low-impact pain was 1.21 (95% CI: 1.07, 1.36) in APOE4-negative individuals, controlling for SCD and relevant biopsychosocial factors. Our findings suggest that high-impact pain is a stronger predictor of future cognitive impairments than SCD alone in most of the population who do not carry the APOE4 allele. Interventions targeting high-impact pain, starting in middle age, may help mitigate the risk of cognitive decline and dementia. Future research is needed to understand potential mechanisms whereby pain either directly or indirectly impacts cognition to develop preventive and effective therapeutic strategies. PERSPECTIVE: This study highlights high-impact pain as a predictor of subjective and objective cognitive decline in older adults. High-impact pain may contribute to cognitive impairment, especially in individuals without the high-risk APOE4 allele, and may represent a modifiable target for early interventions to reduce the risk of dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.